Literature DB >> 23801590

Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration.

Alexandru Hanganu1, Christophe Bedetti, Thomas Jubault, Jean-Francois Gagnon, Béatriz Mejia-Constain, Clotilde Degroot, Anne-Louise Lafontaine, Sylvain Chouinard, Oury Monchi.   

Abstract

Mild cognitive impairment (MCI) can occur early in the course of Parkinson's disease (PD), and its presence increases the risk of developing dementia. Determining the cortical changes associated with MCI in PD, thus, may be useful in predicting the future development of dementia. To address this objective, 37 patients with PD, divided into 2 groups according to the presence or absence MCI (18 with and 19 without) and 16 matched controls, underwent anatomic magnetic resonance imaging. Corticometry analyses were performed to measure the changes in cortical thickness and surface area as well as their correlation with disease duration. Compared with healthy controls, the PD-MCI group exhibited increased atrophy and changes of local surface area in the bilateral occipital, left temporal, and frontal cortices; whereas the PD non-MCI group exhibited only unilateral thinning and decreased surface area in the occipital lobe and in the frontal cortex. In addition, a comparison between the PD-MCI and PD non-MCI groups revealed increased local surface area in the occipital lobe, temporal lobe, and postcentral gyrus for the cognitively impaired patients. It is noteworthy that, in the PD-MCI group, cortical thickness had a significant negative correlation with disease duration in the precentral, supramarginal, occipital, and superior temporal cortices; whereas, in the PD non-MCI group, such a correlation was absent. The findings from this study reveal that, at the same stage of PD evolution, the presence of MCI is associated with a higher level of cortical changes, suggesting that cortical degeneration is increased in patients with PD because of the presence of MCI.
© 2013 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; corticometry; magnetic resonance imaging; mild cognitive impairment; neurodegeneration

Mesh:

Year:  2013        PMID: 23801590     DOI: 10.1002/mds.25541

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  21 in total

Review 1.  Interaction Between Neuropsychiatric Symptoms and Cognitive Performance in Parkinson's Disease: What Do Clinical and Neuroimaging Studies Tell Us?

Authors:  Alexandru Hanganu; Oury Monchi
Journal:  Curr Neurol Neurosci Rep       Date:  2018-10-15       Impact factor: 5.081

2.  Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease.

Authors:  Marianna Amboni; Alessandro Tessitore; Fabrizio Esposito; Gabriella Santangelo; Marina Picillo; Carmine Vitale; Alfonso Giordano; Roberto Erro; Rosa de Micco; Daniele Corbo; Gioacchino Tedeschi; Paolo Barone
Journal:  J Neurol       Date:  2014-11-27       Impact factor: 4.849

3.  Multidelay multiparametric arterial spin labeling perfusion MRI and mild cognitive impairment in early stage Parkinson's disease.

Authors:  Xueling Suo; Du Lei; Lan Cheng; Nannan Li; Panli Zuo; Danny J J Wang; Xiaoqi Huang; Su Lui; Graham J Kemp; Rong Peng; Qiyong Gong
Journal:  Hum Brain Mapp       Date:  2018-12-07       Impact factor: 5.038

4.  The structural changes of gray matter in Parkinson disease patients with mild cognitive impairments.

Authors:  Lihua Li; Bingjun Ji; Ting Zhao; Xuan Cui; Jingtao Chen; Zhenyu Wang
Journal:  PLoS One       Date:  2022-07-20       Impact factor: 3.752

5.  Imaging changes associated with cognitive abnormalities in Parkinson's disease.

Authors:  Yuko Koshimori; Barbara Segura; Leigh Christopher; Nancy Lobaugh; Sarah Duff-Canning; Romina Mizrahi; Clement Hamani; Anthony E Lang; Kelly Aminian; Sylvain Houle; Antonio P Strafella
Journal:  Brain Struct Funct       Date:  2014-05-13       Impact factor: 3.270

Review 6.  Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.

Authors:  Elizabeth R Wallace; Suzanne C Segerstrom; Craig G van Horne; Frederick A Schmitt; Lisa M Koehl
Journal:  Neuropsychol Rev       Date:  2021-04-16       Impact factor: 7.444

7.  Mild behavioral impairment is linked to worse cognition and brain atrophy in Parkinson disease.

Authors:  Eun Jin Yoon; Zahinoor Ismail; Alexandru Hanganu; Mekale Kibreab; Tracy Hammer; Jenelle Cheetham; Iris Kathol; Justyna R Sarna; Davide Martino; Sarah Furtado; Oury Monchi
Journal:  Neurology       Date:  2019-07-18       Impact factor: 11.800

8.  Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study.

Authors:  Elijah Mak; Li Su; Guy B Williams; Michael J Firbank; Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; Adrian M Owen; Tien K Khoo; David J Brooks; James B Rowe; Roger A Barker; David J Burn; John T O'Brien
Journal:  Brain       Date:  2015-07-14       Impact factor: 13.501

9.  Gray and White Matter Contributions to Cognitive Frontostriatal Deficits in Non-Demented Parkinson's Disease.

Authors:  Catherine C Price; Jared Tanner; Peter T Nguyen; Nadine A Schwab; Sandra Mitchell; Elizabeth Slonena; Babette Brumback; Michael S Okun; Thomas H Mareci; Dawn Bowers
Journal:  PLoS One       Date:  2016-01-19       Impact factor: 3.240

Review 10.  Structural Neuroimaging Markers of Cognitive Decline in Parkinson's Disease.

Authors:  Alexandru Hanganu; Oury Monchi
Journal:  Parkinsons Dis       Date:  2016-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.